Preoperative ß-blocker use in coronary artery bypass grafting surgery: National database analysis

JAMA Internal Medicine

Volumn 174, Issue 8, 2014, Pages 1320-1327

  Brinkman, William ^a   Herbert, Morley A ^b   O'Brien, Sean ^c   Filardo, Giovanni ^d   Prince, Syma ^a   Dewey, Todd ^a,b   Magee, Mitchell ^a,b   Ryan, William ^a   Mack, Michael ^a  

^a Cardiopulmonary Research Science and Technology Institute   (United States)

^b Dallas Hospital   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTIFICIAL VENTILATION; ATRIAL FIBRILLATION; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; FACTUAL DATABASE; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; PROPENSITY SCORE; PROTECTION; RENAL INSUFFICIENCY; REOPERATION; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; STROKE; SURGICAL WOUND INFECTION; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ATRIAL FIBRILLATION; COHORT STUDIES; CORONARY ARTERY BYPASS; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROPENSITY SCORE; PROTECTIVE FACTORS; RENAL INSUFFICIENCY; REOPERATION; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STROKE; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 84905841416     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.2356     Document Type: Article

References (28)

1. Viljoen JF, Estafanous FG, Kellner GA. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg. 1972;64(5): 826-830.
2. ZauggM, Tagliente T, Lucchinetti E, et al. Beneficial effects from ß-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology. 1999;91(6): 1674-1686.
3. ten Broecke PW, De Hert SG, Mertens E, Adriaensen HF. Effect of preoperative ß-blockade on perioperative mortality in coronary surgery. Br J Anaesth. 2003;90(1): 27-31.
4. O'Brien SM, Shahian DM, DeLong ER, et al. Quality measurement in adult cardiac surgery, II: statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg. 2007; 83(4)(suppl): S13-S26.
5. Society of Thoracic Surgeons. Quality performance measures. http://www.sts.org/quality-research-patient-safety/quality/quality-performance- measures. Accessed May 8, 2014.
6. National Quality Forum. Quality positioning system. http://www. qualityforum.org/QPS. Accessed May 8, 2014.
7. Ferguson TB Jr, Coombs LP, Peterson ED; Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative ß-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287(17): 2221-2227.
8. Chopra V, Plaisance B, Cavusoglu E, Flanders SA, Eagle KA. Perioperative ß-blockers for major noncardiac surgery: Primum Non Nocere. Am J Med. 2009;122(3): 222-229.
9. Devereaux PJ, Yang H, Yusuf S, et al; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627): 1839-1847.
10. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative ß-blockade: results of theMetoprolol After Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152(5): 983-990.
11. Bouri S, Shun-ShinMJ, Cole GD, Mayet J, Francis DP.Meta-analysis of secure randomised controlled trials of ß-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100(6): 456-464.
12. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative ß-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg. 2007;104(1): 27-41.
13. BrinkmanWT, HerbertMA, Prince SL, et al. Preoperative ß-blocker usage: is it really worthy of being a quality indicator? Ann Thorac Surg. 2011;92 (3): 788-796.
14. Woodhead M. Cardiology update: research fraud masks deaths from perioperative beta blockers. http://www.cardiologyupdate.com.au/latest-news/ research-fraud-concealed-deaths-from-perioperative. Accessed May 8, 2014.
15. Griswold ME, Localio AR, Mulrow C. Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias. Ann Intern Med. 2010;152(6): 393-395.
16. Localio AR, Berlin JA, Ten Have TR, Kimmel SE. Adjustments for center in multicenter studies: an overview. Ann Intern Med. 2001;135(2): 112-123.
17. Berlin JA, Kimmel SE, Ten Have TR, Sammel MD. An empirical comparison of several clustered data approaches under confounding due to cluster effects in the analysis of complications of coronary angioplasty. Biometrics. 1999;55(2): 470-476.
18. Neuhaus JM, Kalbfleisch JD. Between- and within-cluster covariate effects in the analysis of clustered data. Biometrics. 1998;54(2): 638-645.
19. Li F, Zaslavsky AM, Landrum MB. Propensity score weighting with multilevel data. Stat Med. 2013;32(19): 3373-3387.
20. D'Agostino RB Jr, Rubin DB. Estimating and using propensity scores with partially missing data. J AmStat Assoc. 2000;95(451): 749-759.
21. Chen ZM, Pan HC, Chen YP, et al; COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45 852 patients with acutemyocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497): 1622-1632.
22. Devereaux PJ, BeattieWS, Choi PT, et al. How strong is the evidence for the use of perioperative ß blockers in non-cardiac surgery? systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331(7512): 313-321.
23. Fuster V, Rydén LE, Cannom DS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7): e257-e354. doi: 10.1161/CIRCULATIONAHA.106.177292.
24. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: ameta-analysis. Circulation. 2002;106(1): 75-80.
25. Ali IM, Sanalla AA, Clark V. ß-Blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg. 1997;11(6): 1154-1157.
26. Budeus M, Feindt P, Gams E, et al. ß-Blocker prophylaxis for atrial fibrillation after coronary artery bypass grafting in patients with sympathovagal imbalance. Ann Thorac Surg. 2007; 84(1): 61-66.
27. Burgess DC, KilbornMJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: ameta-analysis. Eur Heart J. 2006;27(23): 2846-2857.
28. Hammon JW Jr,Wood AJ, Prager RL,Wood M, Muirhead J, Bender HW Jr. Perioperative ß blockade with propranolol: reduction inmyocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Ann Thorac Surg. 1984;38(4): 363-367.